Several major investors made sizable moves in Indian equities on December 22, with stakes changing hands in pharma, infrastructure, and sugar companies.
Ruby QC Investment Holdings sold its entire 4.62% holding – 7.278 million shares – in Akums Drugs and Pharmaceuticals. The shares were sold to ICICI Prudential Mutual Fund for about ₹311.5 crore, at ₹428 per share. After the sale, Akums stock rose 3.73% to ₹443.15, marking a third straight day of gains.
Azim Premji‑backed Prazim Trading and Investment Company purchased 5.06 crore units (2.6% of the trust) for ₹754.24 crore, paying ₹149.06 per unit. The seller was Vidyaniti LLP, which previously held a 4.64% stake. The trust’s units were trading around ₹149, up 0.57%.
The stock fell 19.5% to ₹3.55 after a prior rally. Multiple funds entered the trade:
These bulk transactions highlight shifting confidence among institutional investors across sectors, from pharma to infrastructure and sugar.
Remember, this is just a snapshot of recent activity, not a prediction. Do your own research before making any investment decisions.
Download the TradeKaizen app to practice F&O trading with real-time market data anytime, anywhere.
Get it on Google PlayConnect with fellow traders, share strategies, and improve your trading skills in our Telegram group.
Join Telegram